Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus

Virology

Volumn 386, Issue 1, 2009, Pages 88-93

  Shirato, Kazuya ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CX3CL1; CX3CR1; Degranulation; HMC 1; Mast cell; Respiratory syncytial virus (RSV)

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; EPITHELIUM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; INOCULATION; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS ATTACHMENT; VIRUS INFECTION; VIRUS REPLICATION;

CELL DEGRANULATION; CELL LINE; COCULTURE TECHNIQUES; EPITHELIAL CELLS; HUMANS; MAST CELLS; RESPIRATORY SYNCYTIAL VIRUSES; TUMOR NECROSIS FACTOR-ALPHA;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 61749086126     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.01.011     Document Type: Article

References (39)

1. Adamko D.J., Yost B.L., Gleich G.J., Fryer A.D., and Jacoby D.B. Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J. Exp. Med. 190 10 (1999) 1465-1478
2. Alwan W.H., Kozlowska W.J., and Openshaw P.J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179 1 (1994) 81-89
3. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 6 Pt 1 (2003) 1442-1446
4. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., and Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 6617 (1997) 640-644
5. Bradding P., Roberts J.A., Britten K.M., Montefort S., Djukanovic R., Mueller R., Heusser C.H., Howarth P.H., and Holgate S.T. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10 5 (1994) 471-480
6. Bradding P., Walls A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117 6 (2006) 1277-1284
7. Brown G., Jeffree C.E., McDonald T., Rixon H.W., Aitken J.D., and Sugrue R.J. Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 327 2 (2004) 175-185
8. Burd P.R., Thompson W.C., Max E.E., and Mills F.C. Activated mast cells produce interleukin 13. J. Exp. Med. 181 4 (1995) 1373-1380
9. Butterfield J.H., Weiler D., Dewald G., and Gleich G.J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 12 4 (1988) 345-355
10. Culley F.J., Pennycook A.M., Tregoning J.S., Hussell T., and Openshaw P.J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 80 9 (2006) 4521-4527
11. Dakhama A., Park J.W., Taube C., Chayama K., Balhorn A., Joetham A., Wei X.D., Fan R.H., Swasey C., Miyahara N., Kodama T., Alvarez A., Takeda K., and Gelfand E.W. The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 170 9 (2004) 952-959
12. Davoine F., Cao M., Wu Y., Ajamian F., Ilarraza R., Kokaji A.I., Moqbel R., and Adamko D.J. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J. Allergy Clin. Immunol. 122 1 (2008) 69-77 77 e1-2
13. Englund J.A., Sullivan C.J., Jordan M.C., Dehner L.P., Vercellotti G.M., and Balfour Jr. H.H. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 109 3 (1988) 203-208
14. Falsey A.R., and Walsh E.E. Respiratory syncytial virus infection in adults. Clin. Microbiol. Rev. 13 3 (2000) 371-384
15. Girard M.P., Cherian T., Pervikov Y., and Kieny M.P. A review of vaccine research and development: human acute respiratory infections. Vaccine 23 50 (2005) 5708-5724
16. Gurish M.F., and Boyce J.A. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J. Allergy Clin. Immunol. 117 6 (2006) 1285-1291
17. Hussell T., Baldwin C.J., O, Garra A., and Openshaw P.J. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27 12 (1997) 3341-3349
18. Jacob C., Yang P.C., Darmoul D., Amadesi S., Saito T., Cottrell G.S., Coelho A.M., Singh P., Grady E.F., Perdue M., and Bunnett N.W. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J. Biol. Chem. 280 36 (2005) 31936-31948
19. Kuypers J., Wright N., and Morrow R. Evaluation of quantitative and type-specific real-time RT-PCR assays for detection of respiratory syncytial virus in respiratory specimens from children. J. Clin. Virol. 31 2 (2004) 123-129
20. McCurdy L.H., and Graham B.S. Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. 2003/01/15 ed. J. Virol. 77 (2003) 1747-1756
21. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170 4 (2003) 1625-1629
22. Nakae S., Ho L.H., Yu M., Monteforte R., Iikura M., Suto H., and Galli S.J. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120 1 (2007) 48-55
23. Nguyen M., Pace A.J., and Koller B.H. Age-induced reprogramming of mast cell degranulation. J. Immunol. 175 9 (2005) 5701-5707
24. Oymar K., Halvorsen T., and Aksnes L. Mast cell activation and leukotriene secretion in wheezing infants. Relation to respiratory syncytial virus and outcome. Pediatr. Allergy Immunol. 17 1 (2006) 37-42
25. Ozawa K., Szallasi Z., Kazanietz M.G., Blumberg P.M., Mischak H., Mushinski J.F., and Beaven M.A. Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 268 3 (1993) 1749-1756
26. Papadopoulos E.J., Fitzhugh D.J., Tkaczyk C., Gilfillan A.M., Sassetti C., Metcalfe D.D., and Hwang S.T. Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur. J. Immunol. 30 8 (2000) 2355-2361
27. Saijo M., Ishii T., Kokubo M., Takimoto M., and Takahashi Y. Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan. Acta. Paediatr. Jpn. 35 3 (1993) 233-237
28. Saijo M., Takahashi S., Kokubo M., Saino T., In-Yaku F., Ishii T., Takimoto M., and Takahashi Y. The role of respiratory syncytial virus in acute bronchiolitis in small children in northern Japan. Acta. Paediatr. Jpn. 36 4 (1994) 371-374
29. Schwarze J., Cieslewicz G., Joetham A., Ikemura T., Hamelmann E., and Gelfand E.W. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162 7 (1999) 4207-4211
30. Sigurs N. Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am. J. Respir. Crit. Care Med. 163 3 Pt. 2 (2001) S2-6
31. Sparer T.E., Matthews S., Hussell T., Rae A.J., Garcia-Barreno B., Melero J.A., and Openshaw P.J. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187 11 (1998) 1921-1926
32. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M., Wright A.L., and Martinez F.D. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 9178 (1999) 541-545
33. Tang Y.W., and Graham B.S. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94 5 (1994) 1953-1958
34. Tracey K.J., and Cerami A. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9 (1993) 317-343
35. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., and Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2 8 (2001) 732-738
36. van Schaik S.M., Tristram D.A., Nagpal I.S., Hintz K.M., Welliver II R.C., and Welliver R.C. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J. Allergy Clin. Immunol. 103 4 (1999) 630-636
37. Volovitz B., Welliver R.C., De Castro G., Krystofik D.A., and Ogra P.L. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr. Res. 24 4 (1988) 504-507
38. Waris M.E., Tsou C., Erdman D.D., Zaki S.R., and Anderson L.J. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70 5 (1996) 2852-2860
39. Waris M.E., Tsou C., Erdman D.D., Day D.B., and Anderson L.J. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. J. Virol. 71 9 (1997) 6935-6939